Search Results - "M. L. Maximov"

PCSK9 Inhibitor Therapy as an Alternative for Statin Intolerance by Shnaider, K. O., Maximov, M. L., Baranova, V. A., Nekipelova, A. A.

“…Scientific relevance. The main cause of cardiovascular pathologies is atherosclerosis, which is secondary to lipid metabolism disorders, in particular, the…”
Get full text

Proprotein convertase subtilisin/kexin type 9 (PCSK9) inhibitors in the treatment of dyslipidemia by Shikaleva, A. A., Maximov, M. L., Kiseleva, N. M.

“…Dyslipidemia makes a substantial contribution to the mortality as one of the leading pathogenetic factors for cardiovascular diseases. The nature and degree of…”
Get full text

Rational mucolytic therapy in respiratory diseases: clinical interpretation of pharmacological properties for informed choice by Lazareva, N. B., Maximov, M. L., Kukes, I. V.

“…Respiratory diseases remain a common group of diseases in the practice of general physicians and pulmonologists. Currently, there are various treatment…”
Get full text

Modern and promising ways of bowel preparation for instrumental research by E. V. Kanner, M. L. Maximov, A. S. Ermolaeva, I. D. Kanner, N. M. Lapkin

“…A review is presented to summarize data on intestinal preparation approaches and methods for research. The historical background and main stages in the…”
Get full text

The role of regulatory T cells in autoimmune thyroiditis by Zhukova, S. I., Kanner, I. D., Mamontova, T. M., Shelomentceva, E. M., Maximov, M. L.

“…Autoimmune thyroiditis is an organ-specific autoimmune disease caused by the activation of self-reactive CD4+ T cells. Regulatory T (Treg) cells are a…”
Get full text

Safety of Use of Russian Biosimilars of Interferon Beta-1b in the Treatment of Multiple Sclerosis: a Meta-analysis of Original Studies by Gudz, D. O., Krasnov, A. E., Mamleev, R. N., Kagirov, R. K., Maximov, M. L.

“…Presently, an active search for  modern drugs for  the  treatment of multiple sclerosis is ongoing. Since  the  treatment with original drugs is expensive,…”
Get full text

Lactobacillus rhamnosus GG: clinical aspects of the use from the perspective of evidence-based medicine by A. V. Gorelov, Е. V. Kanner, M. L. Maximov, A. S. Ermolaeva, A. A. Voznesenskaya, K. N. Dadasheva

“…This review provides information on the composition and functions of the intestinal microbiota, its role in the immune development. At present, prophylactic…”
Get full text

Intestinal microbiota: updated evidence-based data on the efficacy of Lactobacillus rhamnosus GG and Bifidobacterium longum in pediatric practice by A. V. Gorelov, E. V. Kanner, M. L. Maximov, A. S. Ermolaeva, A. A. Voznesenskaya, K. N. Dadasheva

“…The article presents updated data on the composition, formation and role of the intestinal microbiota. It shows the relationship between changes in the…”
Get full text

Pharmacological Correction of Hypoxic Conditions by Complexes of Zinc with N-Alkenylimidazoles by Shakhmardanova, S. A., Maximov, M. L., Parshina, L. N., Trofimov, B. A., Tarasov, V. V., Chubarev, V. N., Arkhipova, S. S., Sologova, S. S.

“…The discovery and development of effective antihypoxic drugs is an important issue in modern experimental and clinical pharmacology. Complexes of zinc…”
Get full text

Drug Safety for Children — International Monitoring Data for 50 Years by Romanov, B. K., Olefir, Yu. V., Alyautdin, R. N., Glagolev, S. V., Polivanov, V. A., Ilienko, L. I., Alpatov, S. P., Bogush, N. V., Buyanova, N. M., Ganshina, I. V., Dibirova, G. O., Dmitrieva, N. B., Zhukova, I. B., Kalinina, E. V., Kirillova, A. V., Kiseleva, N. M., Kukushkin, G. V., Leonteva, T. I., Maximov, M. L., Markina, E. V., Mileshina, S. E., Yurov, D. E.

“…The review article presents a summary of adverse drug reactions (ADR)  in children, information about which was received in 1968–2018 in the International…”
Get full text

RATIONAL CHOICE OF Β-ADRENOBLOCKERS IN CHRONIC HEART FAILURE THERAPY by Maximov, M. L.

“…There were presented results of clinical trials on β-adrenoblockers usage in patients with chronic heart failure (CHF) as well as data of own study on…”
Get full text

RATIONAL CHOICE OF Β-ADRENOBLOCKERS IN CHRONIC HEART FAILURE THERAPY by M. L. Maximov

“…There were presented results of clinical trials on β-adrenoblockers usage in patients with chronic heart failure (CHF) as well as data of own study on…”
Get full text

Modern drugs for obesity and metabolic syndrome treatment (Review) by M. L. Maximov, O. V. Dralova, V. G. Kukes, V. N. Chubarev, V. V. Tarasov

“…The article reviews modern anti-obesity drugs to identify new trends in effective and safe risk factors reduction (diabetes, cardiovascular and musculoskeletal…”
Get full text

SGLT2 inhibitors: control of glycemia and nephroprotection properties by A. A. Volodin, M. L. Maximov, V. G. Slobodyan, R. N. Alyautdin

“…Recently were appeared a fundamentally new insulin-independent approach to the treatment of type 2 diabetes - reduce blood glucose levels by inhibiting…”
Get full text

Clinical efficiency of medium and high doses of valsartan in the treatment of patient with arterial hypertension and chronic kidney diseases by M L Maximov, O V Dralova

“…The results of the study, which shows the efficiency of antihypertensive and nephroprotektive angiotensin II receptor blocker valsartan in patients with…”
Get full text

Angiotensin II receptor antagonist valsartan in treatment of patients with arterial hypertension and chronic kidney diseases. Hypotensive and nephroprotective efficacy by M L Maximov, O V Dralova

“…Angiotensin II receptor blockers are highly effective and safe drugs that reduce the activity of RAAS. Valsartan is a quality, efficient antihypertensive drug…”
Get full text

Clinical application of direct renin inhibitor aliskiren in combined therapy of patients with arterial hypertension and metabolic syndrome by O V Dralova, M L Maximov, A S Ermolaeva

“…The article presents the results of clinical application of direct renin inhibitor aliskiren in combination therapy in patients with arterial hypertension and…”
Get full text

Clinical efficacy of AT1-receptors of angiotensin II valsartan in the pharmacotherapy of patients with arterial hypertension and chronic heart failure by A K Starodubtsev, M L Maximov, O V Dralova, A S Ermolaeva

“…Angiotensin receptor II, combining high efficacy and good tolerability, are one of the main groups of drugs for the treatment of chronic heart failure. The…”
Get full text

Hypertension, obesity, erectile dysfunction. What kind of drug to choose by Maksimov, M L, Ermolaeva, A S, Dralova, O V

“…Hypertension is one of the most common cardiovascular diseases. The development and progression of hypertension is associated with prolonged hyper activation…”
Get more information

An experience with the use of direct renin inhibitor aliskiren in a patient with obesity and arterial hypertension by Maksimov, M L, Ostroumova, O D, Starodubtsev, A K

Get more information